Skip to main content
. 2022 Apr 17;18(1):2061263. doi: 10.1080/15476278.2022.2061263

Figure 3.

Figure 3.

Albumin detection from hepatocyte differentiation in decellularized liver scaffold. A: IHC albumin liver negative control (Mag. 400x), B: IHC albumin liver positive control (Mag. 400x), C: IHC albumin hepatocyte-differentiated MSC d7 in decellularized liver scaffold (Mag. 40x), D: IHC albumin hepatocyte-differentiated iPSC d7 in decellularized liver scaffold (Mag. 40x), E: IHC albumin hepatocyte-differentiated MSC d21 in decellularized liver scaffold (Mag. 40x), F: IHC albumin hepatocyte-differentiated iPSC d21 in decellularized liver scaffold (Mag. 40x), G: Percentage of albumin area fraction using Image J measurement from hepatocyte-differentiated MSCs in decellularized liver scaffold (n = 3), H: Percentage of albumin area fraction using Image J measurement from hepatocyte-differentiated iPSCs in decellularized liver scaffold (n = 3), I: qRT-PCR mean normalized albumin gene expression from hepatocyte-differentiated MSCs in decellularized liver scaffold (n = 3), J: qRT-PCR mean normalized albumin gene expression from hepatocyte-differentiated iPSCs in decellularized liver scaffold (n = 3). Comparison between groups is not significant (p > .5).